Overview
Spexib 150 mg Capsules contain Ceritinib, a targeted therapy classified as an ALK (anaplastic lymphoma kinase) inhibitor. It is used for the treatment of patients with ALK-positive non-small cell lung cancer (NSCLC), especially when the cancer has spread or when previous ALK inhibitors like crizotinib are no longer effective.





